26 related articles for article (PubMed ID: 33183172)
1. Liver receptor homolog-1: structures, related diseases, and drug discovery.
Wu T; Lu ZF; Yu HN; Wu XS; Liu Y; Xu Y
Acta Pharmacol Sin; 2024 Apr; ():. PubMed ID: 38632319
[TBL] [Abstract][Full Text] [Related]
2. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
[TBL] [Abstract][Full Text] [Related]
3. The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway.
Zhang N; Shen H; Chen B; Hu H; Liu C; Chen Y; Cong W
Front Med (Lausanne); 2023; 10():1164656. PubMed ID: 37396899
[TBL] [Abstract][Full Text] [Related]
4. KLF4 transcription factor in tumorigenesis.
He Z; He J; Xie K
Cell Death Discov; 2023 Apr; 9(1):118. PubMed ID: 37031197
[TBL] [Abstract][Full Text] [Related]
5. Potential to Eradicate Cancer Stemness by Targeting Cell Surface GRP78.
Chen HY; Cheng AJ
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883497
[TBL] [Abstract][Full Text] [Related]
6. Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease.
Hemmati SA; Tabein S
Comput Biol Med; 2022 Mar; 142():105228. PubMed ID: 35051855
[TBL] [Abstract][Full Text] [Related]
7. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
Cui J; Jiang W; Wang S; Wang L; Xie K
Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
[TBL] [Abstract][Full Text] [Related]
8. Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.
Nadolny C; Dong X
Cancer Biol Ther; 2015; 16(7):997-1004. PubMed ID: 25951367
[TBL] [Abstract][Full Text] [Related]
9. In silico optimization of peptides that inhibit Wnt/β-catenin signaling.
Fujita M; Tsuchiya K; Kurohara T; Fukuhara K; Misawa T; Demizu Y
Bioorg Med Chem; 2023 Apr; 84():117264. PubMed ID: 37003158
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.
Li C; Dong J; Han Z; Zhang K
Oncol Res; 2017 Apr; 25(4):617-627. PubMed ID: 27983934
[TBL] [Abstract][Full Text] [Related]
12. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
13. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
